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Cell migration and extracellular matrix remodeling are
two essential processes of wound healing, regulated by
extracellular metalloproteinases such as matrix metal-
loproteinase-2 (Gelatinase A) and matrix metallopro-
teinase-9 (Gelatinase B). Expression of matrix metallo-
proteinase-9 is deregulated in numerous wound healing
pathologies. To date the mechanisms regulating matrix
metalloproteinase-9 during normal wound healing are
poorly documented. Using both primary cultures of
normal human keratinocytes and a wounding device
especially designed to dissect the molecular events dur-
ing the healing process in vitro, we show that matrix
metalloproteinase-9 is stimulated by injury in normal
human keratinocytes. This upregulation results from
the mechanical stress created by injury and not from a
soluble factor, secreted by wounded normal human
keratinocytes.We also demonstrate that the Rho family
of small GTPases, p38[MAPK] and JNK together play a
key part in the signaling pathways controlling the sti-
mulation of matrix metalloproteinase-9 in wounded
cells. We provide lines of evidence indicating that in
wounded keratinocytes, upregulation of matrix metal-
loproteinase-9 depends on two distinct pathways. The
¢rst involves Rac1 and/or Cdc42 that control
the activation of p38[MAPK]. The second depends on
RhoA activation that is required for stimulation of
JNK. Key words: JNK/keratinocytes wound healing/matrix
metalloproteinase-9, p38[MAPK]/Rho GTPases. J Invest Der-
matol 121:1291 ^1300, 2003
M
atrix metalloproteinases (MMP) are a family of
extracellular endoproteinases that degrade extra-
cellular matrix (ECM) proteins, such as lami-
nin, ¢bronectin, and collagen. These enzymes
are involved in several physiologic processes
such as development and tissue remodeling but they also contri-
bute to pathologic processes including tumorigenesis and arthritis
(Werb, 1997; Sternlicht andWerb, 2001).
The di¡erent MMPs have been classi¢ed into ¢ve groups in-
cluding gelatinases (MMP-2 and MMP-9), collagenases (MMP-1,
MMP-8, MMP-17, and MMP-13), membrane-type MMP (MT1^
MMP), stromelysins (MMP-3, MMP-10, and MMP-7), and un-
classi¢ed MMP (MMP-11, 12, 19, 26, etc.) (Werb, 1997). These pro-
teases, which are either secreted or membrane bound, are
produced as inactive forms (pro-enzyme) that are activated in
the pericellular environment via an autocatalytic cleavage or by
proteolytic cleavage mediated by other proteinases (Werb, 1997;
John and Tuszynski, 2001). MMPs display a conserved Zn2þ
binding catalytic site and can be inhibited by speci¢c physiologic
inhibitors (Sternlicht andWerb, 2001).
Cutaneous wound healing is a complex process characterized
by the co-ordinated re-epithelization of the epidermis and
restoration of injured connective tissue. During wound healing
the keratinocytes, the endothelial cells, and the ¢broblasts prolif-
erate and migrate into the wound bed (Singer and Clark, 1999).
Cell migration and tissue remodeling require the controlled
degradation of the ECM and the activation of growth factors
(Vassalli and Saurat, 1996). These processes are generally mediated
by serine proteases and MMP family members (Sternlicht and
Werb, 2001). Speci¢cally it has been shown that MMP-2 (72^68
kDa Gelatinase A) and MMP-9 (92^82 kDa Gelatinase B) play an
essential part during healing of wounded skin. MMP-2, which
localizes in the connective tissue ¢broblasts and endothelial cells,
is thought to have an important function during granulation and
the early remodeling phases of repair. MMP-9 is stimulated in res-
ponse to injury and is mostly expressed in the migrating keratino-
cytes sheet (Salo et al, 1994; Munaut et al, 1999; Soo et al, 2000).
MMP-9 catalyzes cleavage of type IV collagen and other base-
ment membrane components (Sternlicht and Werb, 2001).
Recently, the ¢brinogen (Lelongt et al, 2001), interleukin (IL)-1
(Schonbeck et al, 1998), transforming growth factor-b (Yu and
Stamenkovic, 2000), and the hemidesmosomal type XVII col-
lagen (Liu et al, 2000) have been also identi¢ed as MMP-9 sub-
strates. In wounded tissues, expression of MMP-9 parallels the
reabsorption of the provisional matrix and assembly of new
Address correspondence and reprint requests to: Gilles Ponzio INSERM
U 385, FaculteŁ de MeŁ decine Avenue de Vallombrose 06107 Nice cedex 02,
France. Email: ponzio@unice.fr
Abbreviations: AEBSF, 4-(2-aminoethyl) benzenesulfonyl £uoride
MMP, matrix metalloproteinase; JNK, NH2 terminal c-Jun kinase; ECM,
extracellular matrix; SAPK, stress activated protein kinases; MAPK, mito-
gen activated protein kinase; ERK, extracellular signal-regulated kinase;
NHK, normal human keratinocytes; GST, glutathione S transferase; PI3K,
phosphatidylinositol 3 phosphate kinase; ToxA, toxin A of Clostridium di⁄-
cile; exoC3, exoenzyme C3 of Clostridium botulinum.
Manuscript received March 20, 2003; revised May 19, 2003; accepted for
publication July 14, 2003
0022-202X/03/$15.00 . Copyrightr 2003 by The Society for Investigative Dermatology, Inc.
1291
structures of the epidermal/dermal junction; then, the expression
decreases to basal level (Soo et al, 2000). In contrast, £uids from
chronic wound persistently contain high levels of MMP-9 that
probably contribute to abnormal healing of the lesion (Wysocki
et al, 1993; Yager et al, 1996). Indeed, excessive proteinase activity
may degrade growth factors and ECM components required for
the restoration of ECM bed that support migration of the cells co-
lonizing the wound. Therefore, the control of molecular pathways
involved in MMP-9 regulation is an essential requirement for the
healing process and its deregulation may result in abnormal healing.
The molecular pathways involved in regulation of MMP-9 have
been widely investigated in variety of physiologic or physiopatho-
logic systems; however, the mechanisms of MMP-9 regulation
during wound healing are poorly documented. In other contexts,
MMP-9 has been shown to be regulated, at least partially, at the
transcriptional level. Several consensus DNA sequences for tran-
scription factors have been identi¢ed within the promoter of
MMP-9. Activation of activator protein-1 (AP-1) and nuclear fac-
tor-kB (NF-kB) appears to be essential for the induction of MMP-
9 by IL-1 (Yokoo and Kitamura, 1996) or 12-O-tetradecanoyl-
phorbol-13-acetate (Simon et al, 2001). Several consensus binding
sites, including those for Sp1, PEA3, AP-1, Ets, NF-kB, and a reti-
noblastoma binding element, are involved in the transcriptional ac-
tivation of MMP-9 in H-ras and c-myc transformed rat embryo
cell lines (Gum et al, 1997; Himelstein et al, 1997). In the trans-
formed cell systems studied up to date, MMP-9 promoter is driven
by signal transduction pathways involving stress- and mitogen-ac-
tivated protein kinases (p38[MAPK], JNK, and ERK1/2), which are
stimulated either by growth factors, mitogen, cytokines, or envir-
onmental changes (Robinson and Cobb, 1997).
We have recently developed an in vitro wounding system that al-
lows the detection and the quanti¢cation of the molecular events
occurring in keratinocytes and ¢broblasts in response to injury.
Using this device we have reported that injury of normal human
keratinocytes (NHK) stimulated the activation of early signaling
events such as tyrosine kinases, MAP kinases (ERK, p38[MAPK],
and JNK), AP-1 binding activity, and late signaling events such as
laminin-5, MMP-9, ¢bronectin EDA, IL-8, b4 integrin expression
(Turchi et al, 2002). The speci¢c molecular pathways linking these
early and late events, however, remained to be elucidated.
In this study, we dissect one of these pathways, by demonstrat-
ing that the mechanical injury of NHK monolayers stimulates
expression of MMP-9 at mRNA and protein levels, through a
mechanism not described previously, and involving the Rho fa-
mily of guanosine triphosphate (GTP) binding proteins and the
stress kinases JNK and p38[MAPK]. This stimulation likely results
from the mechanical stress created by the injury and does not in-
volve a soluble factor secreted by wounded NHK.
MATERIALS AND METHODS
Reagents Trypsin, ethylenediamine tetraacetic acid, HEPES, penicillin,
and streptomycin were purchased from Invitrogen Corp, Carlsbad, CA.
Dulbecco minimal Eagle’s medium, HamF12, and fetal calf serum were
obtained from Hyclone (Northumberland, UK). Insulin, hydrocortisone,
cholera toxin, human recombinant epidermal growth factor, triiodo-
thyronine, adenine, mitomycin, actinomycin D, and gelatin were purchased
from Sigma (Sigma Aldrich, St. Louis, MO). RNAble, RNA preparation
kit, was from Eurobio (Les Ulis, France). LY294002 SB203580, PD 98059,
and AG-1478 were purchased from Calbiochem (Calbiochem/France,
Meudon, France). BB94 is a kind gift of British Biotech (Oxford, UK).
Clostridium di⁄cile toxin A and Clostridium botulinum C3 exoenzyme were
generous gifts of Drs I. Just (Hanover, Germany) and P. Boquet (Nice,
France), respectively. The cDNA encoding the dominant negative allele of
JNK1 (JNK1(APF)) was described previously (Derijard et al, 1994; Lin et al,
1995) and was a generous gift of Dr B. Derijard (Nice, France).
Isolation and primary culture of human keratinocytes
Isolation NHKwere isolated from healthy neonatal foreskin as described
(Rheinwald and Green, 1975).
Culture cell Keratinocytes were seeded on mitomycin C (10 mg per mL) trea-
ted 3T3-J2 ¢broblasts feeder layers (2  105 cells per cm2) and grown in
‘‘Green’’ medium (2/3 Dulbecco minimal Eagle’s medium, 1/3 HamF12 sup-
plemented with 10% fetal calf serum, HEPES 20 mM, penicillin (1000 U
per mL), streptomycin (1000 U per mL), insulin (5 mg per mL), hydrocorti-
sone (0.4 mm M), cholera toxin (10 mM), recombinant human epidermal
growth factor (10 mM), triiodothyronine (2 mM), and adenine (18 mM).
Immuno£uorescence Con£uent NHK cells were wounded and
incubated at 371C/5% CO2. Twenty-four hours after injury, cells were
washed with phosphate-bu¡ered saline, pH 7.4 and ¢xed in 2%
paraformaldehyde. Cells were then incubated with monoclonal anti-
MMP-9 antibody (1/50) for 1 h at room temperature and with a secondary
£uorescein isothiocyanate conjugated goat anti-mouse antibody (1/50). For
nuclei labeling, cells were incubated for 10 min at room temperature with a
10 ng per mL Hoechst reagent solution.
Protein extracts and immunoblotting analysis Cells wounded or
not for the indicated times were solubilized at 41C in 500 mL RIPA bu¡er
(Tris/HCl 10 mM pH 7.5, NaCl 150 mM, sodium deoxycholate 1%,
nonidet P-40 1%, sodium dodecyl sulfate (SDS) 0.1%, 1 mM
phenylmethylsulfonyl £uoride, 50 mg aprotinin per mL, 50 mg leupeptin
per mL, 1 mg pepstatin A per mL, 20 mM NaF, 1 mM NaVO4, 1 mM b
glycerophosphate). Proteins (100 mg per lane) were resolved on SDS^
polyacrylamide gel electrophoresis and transferred on to Immobilon-P
membrane (Millipore) as described previously (Turchi et al, 2002). The
membrane was saturated with phosphate-bu¡ered saline supplemented
with 3% bovine serum albumin, 0.5% gelatin, and 0.1% Tween 20, and
incubated with either anti-MMP-9 (1/200), anti-phospho/ACTIVE
p38[MAPK] or JNK (1/2000), phospho-speci¢c anti-CREB (1/1000) or -c-
Jun (1/1000) or anti-pan p38[MAPK] (1/10001) antibodies, for 2 h at room
temperature. The membranes were incubated for 1 h at room temperature
with horseradish peroxidase-conjugated goat anti-rabbit IgG (1/4000) and
blots were revealed using the Amersham (Roche/Amersham, Les ULIS,
France) ECL detection system.
Antibodies Monoclonal anti-MMP-9 antibody was obtained from
Research Diagnostic, Inc. (Flanders, NJ) Polyclonal p38[MAPK] (pTPpY)
antibody was purchased from Promega Corporation (Madison,WI) Anti-
phospho-CREB (Ser133) antibody (used to detect phospho-ATF1) was
from Biolabs Inc. (Beverly, MA). Anti-Rho, Rac, Cdc42 monoclonal
antibodies were purchased from Transduction Laboratories (Lexington,
KY). Horseradish peroxidase-conjugated goat anti-rabbit IgG and
£uorescein isothiocyanate-conjugated goat anti-rabbit antibodies were
purchased from Dako. Anti-pan p38[MAPK] antibody was a generous gift
of Dr B. DeŁ rijard (Nice, France).
Rho family of small GTP binding proteins activation (‘‘pull-
down’’ experiments) The activation of cellular Rho, Rac, and Cdc42
was determined by precipitation with the glutathione S transferase (GST)
protein coupled to the Rho binding domain of Rhotekin (Ren et al, 1999)
or to Rac/Cdc42 binding domain of PAK (Manser et al, 1998), according to
the procedure described by Herrmann et al (1995). Brie£y, wounded (or
intact) keratinocytes were lyzed in (1) Rho-speci¢c lysis bu¡er (Tris/HCl 50
mM pH 7.2, NaCl 500 mM, MgCl2 10 mM, Triton X-100 1%, sodium
deoxycholate 0.5%, SDS 0.1%, AEBSF 100 mM, 1 mg leupeptin per mL,
Pepstatine A 1mM), or (2) Rac/Cdc42 speci¢c lysis bu¡er (HEPES 25 mM
pH 7.3, NaCl 150 mM, MgCl2 5 mM, EGTA 0.5 mM,Triton X-100 0.5%,
glycerol 4%, 20 mM b-glycerophosphate, 10 mM NaF, AEBSF 100 mM,
leupeptin 1 mg per mL, Pepstatine A 1 mM). Fifteen milligrams of clari¢ed
protein extracts were incubated with glutathione-Sepharose precoupled with
GST-Rho-BD or GST-Rac-BD protein (30 mg) for 45 to 60 min at 41C.
Beads were washed four times with Rac/Cdc42 lysis bu¡er (for Rac and
Cdc42) or with Tris bu¡er (Tris/HCl 50 mM pH 7.2, NaCl 500 mM,
MgCl2 10 mM,Triton X-100 1%, AEBSF 100 mM, 1 mg leupeptin per mL,
Pepstatine A 1 mM) (for Rho) and denatured in Laemmli bu¡er. GTP-
bound Rho, Rac, and Cdc42 were separated on 12% SDS^polyacrylamide
gel electrophoresis and measured by western blot using monoclonal
antibodies rise against Rho (1/250), Rac (1/10001), and Cdc42 (1/2501).
Northern blot analysis Total RNA from NHKwere isolated using the
RNABle kit according to the manufacturer’s instructions. Northern blot
analysis were carried out using 20 mg of total RNA following the
procedure described previously (Rezzonico et al, 1995). The MMP-9 (458
bp) cDNA probe was obtained by polymerase chain reaction (PCR)
ampli¢cation from NHK total RNA using speci¢c primers, respectively:
forward: 50 -TGGCCCAGGTGACCGGGGCCCTC-30; reverse: 50 -
AAAGGTTAGAGAATCCAAGTTTAT-30.
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Gelatin zymography Aliquots (5 mL) of culture medium correspond-
ing to the di¡erent experimental conditions were applied on 10%
polyacrylamide gel containing 0.3% gelatin. The gels were incubated in
2.5% Triton X-100 for 2 h, then incubated for 18 h at 371C in 100 mM
Tris/HCl, pH 7.5, 200 mM NaCl, 1 mM CaCl2, and 1 mM MgCl2. The
gels were ¢nally stained with Coomassie Brilliant Blue.
Retroviral infection and isolation of NHK expressing the JNK
(APF) dominant negative allele of JNK1
Plasmid construction The full-length open reading frame of the cDNA
encoding the dominant negative JNK (APF) allele of JNK (a gift of
Dr Derijard, Nice France), was subcloned downstream the mouse Moloney
murine leukemia virus (MMLV) long-term repeat (LTR) of Plasmid
pLZRS-Ires-Zeo (Gift of G.P. Nolan, Standford University, California).
Plasmids (pLZRS-Ires-Zeo-JNK(APF) were ampli¢ed into Escherichia coli
XL10 strain and puri¢ed using QIAquick kit (Qiagen Inc., Chatsworth, CA).
Retroviral infection Infectious recombinant retrovirus were generated by
transfecting the recombinant plasmid pLZRS-Ires-Zeo-JNK (APF) into
the amphotropic Phoenix packaging cells by the calcium phosphate preci-
pitation method (Michiels et al, 2000). The supernatant from these cultures
(about 2.5  104 colony forming units (cfu) per mL) were collected after
48 h and applied for 24 h at 321C to NHK seeded at 3  104 cells per cm2
on a feeder of J2-3T3 ¢broblasts. Cells were fed with fresh medium for 2 d
and were selected in the presence of 200 mg zeocin per mL.
Reverse transcriptase^PCR Total NHK RNA (2 mg) was reverse-
transcribed at 371C for 60 min, using Omniscript Kit (Promega,
Madison,WI). Two microliters of each cDNA sample were used for PCR
using TAQ polymerase (Life Technologies, Inc.). The cDNA encoding
MMP-9 and GAPDH were ampli¢ed using the speci¢c sets of
primers, respectively: forward: 50 -TGGCCCAGGTGACCGGGGCCCTC-30;
reverse: 50 -AAAGGTTAGAGAATCCAAGTTTAT-30, and forward: 50 -ATGG-
GGAAGGTGAAGGTCGG-3; reverse: 50 -TTACTCCTTGGAGGCCATGT-30.
Quantitation of northern and western blot analysis The RNA and
proteins were quantitated using two methods: (1) by densitometric
scanning using a computerized microscopic image processor Biocom 500
(Biocom, les Ulis France) comprising a PC/AT-compatible microcomputer,
a real-time imaging processor, a control monitor, a color high de¢nition
monitor, and a Panasonic WV-CD50 camera, and (2) Using the NIH
image software available on web site: http://rsb.info.nih.gov/nih-image/
RESULTS
De novo expression of activated-MMP-9 metalloprotease
at the edges of wounded keratinocytes To dissect the
molecular pathways involved in the regulation of the metallo-
protease MMP-9 (Gelatinase B) during epidermal wound
healing in vitro, we have used NHK and a new technologic
approach specially designed for this purpose and already
described (Turchi et al, 2002).
A con£uent monolayer of primary human keratinocytes was
mechanically injured as described in Materials and Methods. After
24 h, the healing cultures were analyzed by immuno£uorescence
after labeling with Hoechst reagent, which allows the
identi¢cation of keratinocytes migrating from the edge (dotted
line) into the wound bed (arrows) (Fig 1A). Interestingly, the
wound closure was totally impaired when cells were incubated,
before injury, with 20 mM of BB94, a wide spectrum metallo-
proteinases inhibitors (Davies et al, 1993), indicating that, in our
biologic system, MMP are involved in wound repair.
Using a speci¢c anti-MMP-9 antibody, we clearly observed
that the protease MMP-9 was upregulated in wounded NHK
and was speci¢cally expressed in cells forming the migrating
front (Fig 1B, arrows). Upregulation of MMP-9 in the wounded
cultures was further demonstrated at the molecular level by
gelatinolytic zymography, western and northern blots (Fig 1C).
Results demonstrated that MMP-9 increased between 6 h and
24 h after injury of the cell layers (Fig 1C), then was
downregulated to the basal level after 48 h (not shown). In
zymography and immunoblots, MMP-9 can be detected as a
double band identifying the inactive form (pro-enzyme 92 kDa)
and the active (82 kDa) enzyme form (Fig 1C). Here we show
that, in wounded keratinocyte cultures, MMP-9 is mostly
expressed in its active form. This observation and the fact that
MMP-9 was exclusively visualized by immuno£uorescence in
keratinocytes located at the edge of the wound (Fig 1B) support
the idea that MMP-9 is involved in the degradation of ECM
deposed by the cultured keratinocytes and the 3T3-J2 ¢broblasts
(Rheinwald and Green, 1975), and consequently that MMP-9 is
active in the healing process. Our data also show a good correla-
tion between the variations in the steady-state levels of MMP-9
mRNA, expression of the protein, and enzymatic activity. This
suggests that upregulation of MMP-9 mainly resulted from en-
hanced expression of MMP-9 mRNA transcripts consequent to
mechanical injury of the cell culture.
The gelatinolytic activity of the conditioned medium of
keratinocyte cultures also revealed that MMP-2 (Gelatinase A) is
secreted by unwounded cell cultures. In contrast to MMP-9,
however, expression of MMP-2 was not upregulated following
injury, con¢rming the observation reported by others (Salo et al,
1994).
MMP-9 induction was not mediated by a soluble secreted
factor MMP-9 is stimulated by chemicals (phorbol myristate
acetate), growth factors, and cytokines. Some of which (trans-
forming growth factor-b, IL-1, tumor necrosis factor-a) are
upregulated during wound healing (Salo et al, 1994; Holzheimer
and Steinmetz, 2000; Han et al, 2001; Turchi et al, 2002). To assess
whether induction of MMP-9 could be mediated by a second
messenger released by wounded keratinocytes, we tested the
ability of spent medium of injured NHK cultures to upregulate
the expression of MMP-9 in exponentially growing and
quiescent keratinocytes. The MMP-9 gelatinolytic activity
present in the conditioned medium of NHK and 3, 6, and 12 h
after wounding is presented in Fig 2A, respectively lanes 1, 2, 3,
4. Exposure for 24 h of proliferating NHK to such conditioned
medium had no e¡ect on MMP-9 activity (Fig 2B). Indeed, the
activity of MMP-9 in the culture medium of exponentially
growing cells (Fig 2B) did not increase compared with the
activity present in the conditioned medium of wounded cells
(Fig 2A). The same results were obtained when the condi-
tioned medium was added to con£uent keratinocyte cultures
(not shown). To con¢rm these data we performed reverse trans-
criptase^PCR experiments using RNA obtained from (1)
keratinocytes before and 12 h after injury, and of (2) 50%
con£uent intact NHK treated for 24 h with the conditioned
medium of NHK harvested, 6 and 12 h after wounding. The
results indicate that MMP-9 mRNAwas stimulated in NHK 12
h after injury (Fig 2B, left panel) but not when intact keratin-
ocytes were incubated for 24 h with the spent medium of
wounded cells (Fig 2B, right panel).
These results support the data presented in Fig 2(A) and
demonstrate that the conditioned medium of wounded
keratinocytes does not contain secreted soluble factors able to
stimulate MMP-9 in unwounded cells. This idea is in agreement
with the observation that upregulation of MMP-9 is restricted to
the wound edge of injured keratinocyte cell cultures as deter-
mined by immuno£uorescence studies (Fig 1B).
p38[MAPK] is involved in MMP-9 induction To characterize
further the pathways regulating induction of MMP-9 in
wounded NHK, we tested the e¡ects of known pharmacologic
inhibitors on the expression of MMP-9 at mRNA levels and
gelatinolytic activity of the enzyme. The chosen inhibitors were
LY 294002, a phosphatidylinositol 3 phosphate kinase (PI3K)
inhibitor, PD 98059, a MEK-1 inhibitor, SB 203590, a p38[MAPK]
inhibitor, and tyrphostin AG1472, an inhibitor of epidermal
growth factor receptor activity. The results shown in Fig 3(A)
show that exposure to SB 203590 before wounding inhibited
totally the enzymatic activity of MMP-9, indicating an
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involvement of p38[MAPK] in the signaling cascade leading to
MMP-9 upregulation in response to injury. In contrast, no
appreciable e¡ect was observed when NHK were wounded in
presence of the other inhibitors. Using anti-phospho/active
speci¢c anti-p38[MAPK] antibodies, we con¢rmed that p38[MAPK]
was stimulated in NHK, in response to injury (Fig 3B). The
stimulation was rapid and transient with a maximal activity
detected between 8 and 15 min. We veri¢ed that SB 203580
e⁄ciently inhibited p38[MAPK] in wounded cells by showing the
inhibition of phosphorylation of ATF1, one of p38[MAPK]
physiologic substrates (Fig 3C). We also veri¢ed that, at a
concentration that blocked MMP-9 activity, SB 203580 had no
e¡ect on phosphorylation of c-Jun, which indicates that SB
203580 does not inhibit JNK a kinase related to p38[MAPK] (Fig
3C). Interestingly, at the same time as MMP-9 inhibition, we
showed that the treatment of wounded cells with SB 203580 but
not with inhibitors such as LY 294002, PD 98059, or tyrphostin
AG1472 leads to a marked reduction in the number of cells that
migrate into the wound bed (‘‘wound closure’’) (Fig 3A, inset),
suggesting that the genes controlled by the p38[MAPK] pathway
(including MMP-9) play a predominant part in NHK wound
closure.
To determine the mechanism by which SB 203580 decreases
the gelatinolytic activity of MMP-9, we analyzed the level of
MMP-9 mRNA in cell cultures treated with SB 203580.
Northern blot analysis of wounded cell cultures showed that SB
203580 speci¢cally inhibited MMP-9 mRNA expression,
whereas LY 294002, PD 98059, and AG 1478 did not (Fig 4A).
SB 203580 inhibition was concentration dependent with a half-
inhibitory e¡ect at a concentration lower than 4 mM (Fig 4B).
This observation discloses the role of p38[MAPK] as a key
intermediate in the cascade of events controlling synthesis of
MMP-9 mRNA. Beside this pharmacologic approach, we also
tried to develop a dominant negative (dn) mutant of p38
[MAPK] using a retroviral strategy (see experimental details in
the following paragraph). Surprisingly, however, it appeared that
the expression of dn form of p38[MAPK] (T180A/Y182F) was
lethal and, after three di¡erent attempts, it was impossible to get
p38dn expressing NHK clones.
MMP-9 expression upon wounding required the NH2
terminal c-Jun kinase (JNK) pathways To examine the
possible involvement of JNK in the signaling cascade leading to
MMP-9 induction, we tested the e¡ect of a dominant negative
allele of JNK1 (JNK1(APF)) on MMP-9 expression and
gelatinolytic activity after injury of a con£uent monolayer of
NHK. JNK1 (APF) corresponded to a JNK1 variant in which
alanine and phenylalanine residues respectively substitute
threonine 183 (T183) and tyrosine 185 (Y185). In wild-type cells,
T183 and Y185 are phosphorylated in response to JNKK/SEK1/
MKK4 activation and are required for activation of JNK
(Derijard et al, 1994; Lin et al, 1995). The cDNA for JNK1(APF)
Figure1. (A) E¡ect of MMP inhibitor on the
migration of wounded NHK. Con£uent kera-
tinocytes were wounded in the absence (control)
or in the presence of the MMP inhibitor BB94
(20 mM) and ¢xed after 24 h in 2% paraformal-
dehyde. The cells were visualized by immuno-
£uorescence staining by labeling of nuclei with
Hoescht reagent. Dotted lines highlight the
wound edges and arrows the ‘‘wound bed’’. The
histograms on the right part represent a typical
wound closure time course. The percentage of
wound closure corresponds to the area ¢lled by
the ‘‘healing’’ NHK at indicated times compared
with the total wound bed area measured immedi-
ately after injury. The measurements were made
using an inverted microscope ¢tted with a cali-
brated ocular grid (B) Immunochemical localiza-
tion of MMP-9 in migrating cells. Wounded
NHKwere maintained in culture for 15 h, ¢xed,
then stained using either a nonrelevant serum
(NIS) or speci¢c anti-MMP-9 antibody (anti-
MMP-9). Arrows indicate the MMP-9 positive
cells. (C) Biochemical characterization of MMP-
9 in injured NHK. MMP-9 was measured 3, 6, 12,
and 24 h after injury either in the culture medium
by zymogram analysis (upper panel) or in cell pro-
tein extracts by western blot analysis (middle panel)
or in total RNA extracts by northern blot analy-
sis (lower panel). ‘‘N’’designates the level of MMP-
9 in unwounded NHK. 28S RNA used as load-
ing control. The presented experiment is a typical
one among ¢ve independent experiments.
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was inserted into the retroviral vector LZRS-IRES-ZEO
(Michiels et al, 2000) and transduced into keratinocytes. Stable
NHK transduced clones were selected in the presence of zeocin
and used in wounding assays.Western blot analysis of lysates of
infected cells using a speci¢c anti-JNK antibody showed the
e⁄cient transduction of JNK in the recipient cells (Fig 5A, top
panel). The level of JNK1 expression was at least 50-fold higher
than the level of endogenous JNK measured in NHK infected
with an empty vector (mock). Analysis of JNK activity in the
JNK(APF) expressing cells was assessed by western blot using
anti-phospho/active JNK antibodies. The ectopic expression of
JNK1(APF) in wounded cultures was found to inhibit by more
than 80% the phosphorylation of JNK (Fig 5A, bottom panel).
Immuno£uorescence analysis of the transduced cell cultures using
an anti-JNK antibody suggested that the background activity of
JNKwas likely due to the presence of a subpopulation of zeocin-
resistant cells that did not express JNK(APF) (data not shown).
As shown in Fig 5(C), the expression of JNK(APF) did not
impair the stimulation of p38[MAPK] and ERK1/2 activities in
the wounded JNK(APF) NHK.
The e¡ect of injury on the MMP-9 protein expression and
gelatinolytic activity was assessed in both JNK(APF) and control
keratinocytes. Interestingly, in wounded cells, the level of
MMP-9 and its enzymatic activity were strongly inhibited in
JNK(APF) expressing keratinocytes as compared with controls
(Fig 5B), which indicates that activation of JNK is required for
the stimulation of MMP-9. In view of these results, we
concluded that the upregulation of MMP-9, in wounded
epidermal keratinocytes, requires the activation of both
p38[MAPK] and JNK.
In injured cells the induction MMP-9 involved the Rho
family of small GTPases Previous studies demonstrated that
the activation of the Rho family members, namely the small
GTP binding proteins Rho, Rac, and Cdc42, is an essential step
for actin reorganization during the healing process (Nobes and
Hall, 1999). Because these small GTPases are also involved in the
activation of JNK and p38[MAPK] (Bagrodia et al, 1995; Zhang
et al, 1995), we investigated their roles in the molecular cascade
responsible for MMP-9 stimulation after wounding. First, we
inquired whether cell injury induces activation of the small GTP
binding proteins RhoA, Rac, and Cdc 42. The extent of Rho
GTPases activation was measured by classical pull-down
experiments 3 min after injury, using recombinant GST fusion
proteins containing (1) the Rho binding domain of rhotekin, to
measure RhoA activation (Ren et al, 1999), and (2) the Cdc42 and
Rac binding domain of PAK to measure Cdc42 and Rac
activities (Manser et al, 1998).We demonstrated, for the ¢rst time,
that con£uent NHK cultures wounding resulted in a strong
activation of the three GTPases RhoA, Rac, and Cdc42
(Fig 6).
To de¢ne the role of these proteins in MMP-9 activation, we
analyzed the e¡ect of Rho GTPases-inhibiting toxins on (1)
MMP-9 activity and mRNA expression, and (2) on JNK and
p38[MAPK] activities. The toxins used were toxin A of Clostridium
di⁄cile (ToxA), a broad Rho GTPases inhibitor inactivating
RhoA, Rac, and Cdc42, and Exoenzyme C3 of Clostridium
botulinum (exoC3), a RhoA speci¢c inhibitor. When cells were
preincubated with ToxA (500 nM) and exoC3 (40 mg per mL)
before wounding, MMP-9 activity and mRNA expression were
inhibited by more than 90% (Fig 7A), indicating that the
activation of small GTPases is required for induction of MMP-9.
The e¡ect of ToxA and exoC3 appeared to be speci¢c as these
toxins did not a¡ect the activity of MMP-2, another
metalloprotease highly expressed in NHK (Fig 7A, top panel).
Examination of the e¡ects of Rho GTPases-inhibiting toxins
on injury-stimulated JNK and p38[MAPK] activities shows that
exposure of NHK toToxA resulted in inhibition of activation of
both kinases (Fig 7B). This suggests that p38[MAPK] and JNK
stimulation lays downstream Rho GTPases in the MMP-9
activation cascade triggered by injury. To investigate further the
speci¢city of JNK/p38 activation by Rho GTPases during
reparation, we investigated the e¡ect of exoC3 on wounded
cells. In contrast to ToxA, treatment of NHK with exoC3
speci¢cally inhibited JNK but was ine¡ective on the p38[MAPK]
activity (Fig 7C) indicating that, in response to injury, activation
of RhoA is mandatory for stimulation of JNK but not for the
activation of p38[MAPK]. In addition, the fact that p38[MAPK] was
inhibited by ToxA but not by exoC3 indicates that p38[MAPK]
stimulation is consequent to activation of Rac and/or Cdc42.
ToxA and exoC3 are known to cause disorganization of the
actin cytoskeleton (Aktories et al, 2000). To determine whether,
in our system, MMP-9 resulted from the e¡ect of GTPases on
actin cytoskeleton, we submitted the wounded cells to a
treatment by cytochalasin B, an agent that depolymerizes the
actin cytoskeleton. Cells were incubated for 4 h with 1 and 5
mM of cytochalasin B, then wounded. MMP-9 RNA expression
was measured 15 h after injury by northern blot analysis. The
results shown in Fig 7(D) demonstrated that the actin
cytoskeleton depolymerization itself had no e¡ect on the
induction of MMP-9 transcription. According to these results,
stimulation of MMP-9 expression mediated by injury was
independent from the changes in the cellular actin cytoskeleton.
DISCUSSION
Epidermal keratinocytes produce a large spectrum of the protei-
nases involved in ECM remodeling during wound healing, inva-
sion, squamous cell carcinoma, and other pathologic situations of
the skin (Johnsen et al, 1998; Kahari and Saarialho-Kere, 1999;
Figure 2. MMP-9 induction was not mediated by a soluble secreted
factor. (A) MMP-9 gelatinolytic activity measured in the conditioned
medium of con£uent NHK, 3, 6, and 15 h after wounding (lanes 2^4). Lane
1 represents the MMP-9 activity in the medium of unwounded NHK. (B)
The conditioned medium of NHK unwounded (lane 1) or NHK cultures 3,
6, and 15 h after wounding (respectively lanes 2, 3, 4) was added to subcon-
£uent NHK.The MMP-9 activity present in the culture mediumwas mea-
sured 15 h later by zymography. Data are representative results from one
experiment of three. (C) (Left upper panel), analysis by PCR of MMP-9
RNA expression in NHK, before wounding (N) and 12 h after injury
(W).The right upper panel represents the level of MMP-9 detected by reverse
transcriptase^PCR using RNA puri¢ed from 50% con£uent NHK incu-
bated for 24 h with the conditioned medium of NHK before (1) and 6 h (2)
or 12 h (3) after injury. The lower panel represents the level of GAPDH
cDNA shown as a control for the reverse transcriptase^PCR reaction.
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Westermarck and Kahari, 1999). MMP-9/gelatinase B appears to
be particularly important for keratinocyte migration during re-
epithelialization of cutaneous wounds (Salo et al, 1994; Okada
et al, 1997; Madlener et al, 1998) and invasion of tumors (Wester-
marck and Kahari, 1999; Kanayama, 2001). Clinical studies have
demonstrated that MMP-9 is deregulated in leg ulcers (Wysocki
et al, 1993; Yager et al, 1996) or keloids (Neely et al, 1999). These
observations strongly suggest that MMP-9 stimulation is a crucial
element in the regulation of the healing process. So far, however,
the mechanisms responsible for MMP-9 regulation have not been
thoroughly investigated in the context of wound healing. Indeed,
the large majority of the studies concerning the mechanisms of
Figure 3. E¡ect of kinase inhibitor on
injury-stimulated MMP-9 activity during
wound healing. (A) Con£uent NHKwere incu-
bated for 2 h in the absence (Ct) or in the pre-
sence of kinase inhibitors: SB203580 (30 mM)
(SB), PD98059 20 mM (PD), LY 294002 (10 mM)
(LY), and tyrphostin AG1472 (100 nM) then
wounded (W) or left intact (N). Fifteen hours
after injury, MMP-9 activity was measured in cul-
ture medium by zymography. (B) E¡ect of
wound healing on p38[MAPK] activity measured
by western blot analysis of cell extracts.Top panel.
Con£uent human keratinocytes were wounded
(W) and harvested after 8, 15, 60, and 180 min.
Cells were lyzed and p38[MAPK] activity in cell ex-
tract was measured using anti-p38 antibodies to
the phosphorylated/active form of p38[MAPK]
(p38-p). (N) represents the p38[MAPK] activity in
unwounded cells. (C) E¡ect of SB 203580 on
p38[MAPK] and JNK activity. Cells were preincu-
bated for 2 h with 20 mM of SB203580, then
wounded (W) or left intact (N). Thirty minutes
after injury, the cells were lyzed, and phosphory-
lation of ATF1 and c-Jun was measured using
antibodies to the phosphorylated form of ATF 1
(ATF-P) and c-Jun (c-Jun-P). This experiment
was performed three times. The inset represents
the e¡ect of kinase inhibitors (SB, PD, LY, and
AG) on the wound closure determined by mea-
suring the surface of the ‘‘wound grooves’’ sponta-
neously covered by the keratinocytes 15 h after
injury (ct).
Figure 4. E¡ect of pharmacologic inhibitors
on MMP-9 mRNA expression. (A) Top panel:
Con£uent NHK were preincubated for 2 h in
the presence of SB 203580 (30 mM) (SB), PD
95059 (20 mM) (PD), and LY 294002 (10 mM)
(LY) then wounded (W) or left intact (N). After
15 h, the cells were lyzed, RNA extracted and the
steady-state level of MMP-9 mRNA was mea-
sured by northern blot analysis using 32P labeled
MMP-9 cDNA. The 28S RNA is the sample
loading control. Bottom panel. E¡ect of tyrphostin
AG1478 on MMP-9 mRNA expression. Cells
were preincubated with AG1472 (100 nM) then
wounded and treated as described above. MMP-
9 was measured by northern blot analysis. (B)
Dose^response of SB203580 on MMP-9 tran-
scription in wounded NHK. Cells were preincu-
bated for 2 h at the indicated concentrations of
SB 203580. Wounded (W) or unwounded cells
(N) were harvested 24 h later. Expression of
MMP-9 mRNA was analyzed by northern blot.
The histogram represented the relative intensity
of each band quanti¢ed using the methods de-
scribed in Materials and Methods. Data are repre-
sentative of at least three distinct experiments.
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MMP-9 regulation have been performed on tumor cells in which
MMP-9 is constitutively upregulated (Simon et al, 1998, 1999;
Ikebe et al, 1999; Kupferman et al, 2000).
To deepen our knowledge on molecular mechanisms regulat-
ing MMP-9 in human keratinocytes during wound healing, we
have used a wounding device that allows the qualitative and
quantitative detection of the signaling pathways activated in the
repair process in vitro (Turchi et al, 2002). By this approach, the
enzymatic activity, the mRNA and the protein expression of
MMP-9 can be assayed simultaneously by zymography, northern
and western blot analysis, which was not possible using the
wounding models classically available to study wound healing in
vitro (Dieckgraefe et al, 1997; Goke et al, 1998; Pintucci et al, 1999).
Here, we show that a mechanical injury of NHK stimulates ex-
pression of MMP-9 and that this stimulation speci¢cally occurs
in the cells situated at the wound edge. As reported in vivo (Pirila
et al, 2001), in our model of wound healing, MMP-9 likely parti-
cipates in the ECM digestion, an essential step of the wound
healing process. We also present evidence that in wounded
NHK, MMP-9 stimulation results from the upregulation of its
mRNA expression, likely by a transcriptional mechanism.
The ¢rst major question raised by our observations was to
know whether the stimulation of MMP-9 was the result of the
action of soluble factor(s) secreted by wounded cells in response
to injury or was the consequence of the physical modi¢cation oc-
curring at the membrane level when the integrity of the con£u-
Figure 5. E¡ect of JNK inactivation on MMP-9
expression and enzymatic activity. (A) Analysis
of JNK expression and activity in wild-type NHK
(mock) and in NHK expressing a dominant nega-
tive mutant gene of JNK1 (JNK1(APF)) (see Materi-
als and Methods). Wounded or intact wild-type
(Mock) and JNK1(APF) human keratinocytes were
harvested 15 min after wounding. Cells lysates were
prepared then expression of JNK (top panel) and its
activity (bottom panel) were measured by Western
blot analysis using an anti-pan JNK or an anti-phos-
pho/active JNK antibody, respectively. (B) E¡ect of
JNK inactivation on MMP-9 expression and gelati-
nolytic activity. Con£uent wild-type (mock) and
JNK1(APF)) NHKwere wounded or not, then left
to heal for 15 or 24 h at 371C. The culture media
were then collected and cells were lyzed to prepare
protein extracts harvested. (Left) MMP-9 protein
expression was measured by western blotting (WB)
using an anti-MMP-9 antibody. (Right) the gelati-
nolytic activity was measured by zymography of cell
culture medium 24 h after wounding. (C) E¡ect of
JNK inactivation on p38[MAPK] and ERK1/2 activ-
ities. Wild-type and JNK(APF) keratinocytes were
wounded and cell lysates were separated on SDS^
polyacrylamide gel electrophoresis, then ERK1/2
and p38[MAPK] activities were estimated using speci-
¢c anti-phospho/active ERK1/2 and p38[MAPK] anti-
bodies, respectively. Data are from a representative
experiment out of three.
Figure 6. E¡ect of wound healing on the activation of small GTP binding proteins. Con£uent NHKwere wounded (W) or left intact (N) and
harvested 3 min later. Cells were lyzed, and the active GTP-bound form of RhoA, Rac, and Cdc42 were measured by pull-down (Materials and Methods)
using recombinant polypeptides corresponding to the Rho binding domain of Rothekin or to Rac/Cdc42 binding domain of PAK. GTP-bound RhoA,
Rac and Cdc42 expression was assessed by western blot analysis on total protein extracts (T) and pull-down pellets (P) (left panel). (N) corresponds to the
level of Rho, Rac, and Cdc42 in unwounded cells. Right panel: quanti¢cation of western blot experiments presented on left panel. The activation levels of
RhoA, Rac, and Cdc42 (GTP-bound) were in the same order of magnitude and represented, respectively, 12-, 5-, and 9-fold the basal value measured
before injury.
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ent NHK monolayer was broken. Indeed, several soluble factors,
including tumor necrosis factor-a, IL-1, and transforming
growth factor-b are known to induce MMP-9 in keratinocytes
when added to cultured cells (Salo et al, 1994; Han et al, 2001).
Some of them are upregulated in wounded tissues and cell cul-
tures (Holzheimer and Steinmetz, 2000; Turchi et al, 2002) and
therefore constitute potential intermediates in injury-mediated
MMP-9 stimulation. It has not been clearly demonstrated, how-
ever, whether the amounts of endogenous factors, produced at
the wound site, are able to stimulate MMP-9 e⁄ciently. Using
conditioned media of wounded NHK cultures, we show that
MMP-9 stimulation is apparently not mediated by soluble factors
released in response to injury. This conclusion suggests that the
mechanical disruption of wounded keratinocyte monolayers
may, by itself, directly induce the signaling cascade leading to
MMP-9 upregulation. This hypothesis is in agreement with nu-
merous studies demonstrating that mechanical forces generate
signals that in£uence the cell morphology and activate small
GTPases, stress kinases, and a variety of genes, including trans-
forming growth factor-b, collagen, or MMP-9 (Jin et al, 2000;
Lambert et al, 2001; Swartz et al, 2001). This hypothesis also ex-
plains why the MMP-9 is stimulated exclusively in keratinocytes
situated at the wound edge and not in the whole cell population.
The second aim of this study was to gain new insights on the
molecular cascades underlying MMP-9 stimulation in response to
cell injury. Using inhibitors of small GTPases family, the SB
203580, a p38[MAPK] inhibitor, and transfection of keratinocytes
with a dominant negative variant of JNK1, we demonstrate that,
in healing keratinocytes, MMP-9 is under the control of a mole-
cular cascade involving the small GTP binding proteins RhoA,
Rac, and Cdc42 and the MAP kinases JNK and p38[MAPK].
The MAP kinases, ERK1/2, p38[MAPK], and JNK have been
involved in the signaling pathways controlling a variety of
MMP (Mengshol et al, 2001; Leivonen et al, 2002; Reunanen
Figure 7. E¡ect of ToxA and exoC3 on (1) MMP-9 expression, and (2) JNK and p38[MAPK] activities. (A) Con£uent NHK preincubated for 6 h in
the presence of ToxA (500 nM), or 18 h in the presence of exoC3 (40 mM), were wounded (W) and harvested after 15 h. The culture medium was collected
and total RNAwere puri¢ed from cells. MMP-9 was quanti¢ed by zymography in the culture medium (top panels) or by northern blot analysis of total
cellular RNA (bottom panels). (Ct) represents MMP-9 enzymatic activity and mRNA expression in wounded in the absence of toxin. (N) correspond to the
level of MMP-9 present in unwounded cells. (B) Con£uent NHKwere incubated for 6 h with ToxAwounded (W) and harvested 15 min after wounding.
Cells were lyzed and p38[MAPK] and JNK activities were assayed by western blotting using antibodies against the phosphorylated/active forms of p38 (p38-
p) and JNK (JNK-p). The bottom panels represent the total expression of p38[MAPK] and JNK estimated by western blotting using anti-pan p38 and anti-pan
JNK antibodies, respectively. (N) corresponds to the level of p38[MAPK] and JNK present in unwounded cells. (C) NHKwere incubated for 18 h with exoC3
before injury and analysis of p38[MAPK] and JNK activities as described in (B). The data are from one typical experiment chosen from three distinct experi-
ments. The quanti¢cation of JNK and p38 inhibition by ToxA and exoC3, achieved using the methods described in Materials and Methods, indicates that
ToxA inhibits 81% of p38 MAPK activity and 75% of JNK activity and that exoC3 inhibits 89% of JNK activity but has no inhibitory e¡ect on p38
MAPK. (D) E¡ect of cytochalasin B on MMP-9 expression. Con£uent NHKwere preincubated for 2 h with 1 mM and 5 mM cytochalasin B (Cyt B) before
wounding. The cellular RNAwere extracted 15 h after injury and MMP-9 expression was measured by northern blot analysis as described in Materials and
Methods. (Ct) represents the MMP-9 mRNA expression in absence of cytochalasin B.
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et al, 2002). To date, the role of MAPK in the regulation of
MMP-9 has been essentially demonstrated in cancer cells, includ-
ing transformed keratinocytes (Francisco Santibanez et al, 2002),
human squamous carcinoma cell lines (Gum et al, 1997; Simon
et al, 1998), neck carcinoma cells (Simon et al, 1999), and breast
cancer cells (Yao et al, 2001), but not in physiologic processes such
as wound healing. In this study we demonstrate that p38[MAPK]
and JNK but not ERK1/2 are involved in MMP-9 stimulation
during wound healing of primary human epidermal keratino-
cytes. Interestingly, we show that stimulation of MMP-9 requires
the concomitant activation of both JNK and p38[MAPK], because
the inhibition of one of these kinases totally prevents MMP-9
upregulation.
In a recent study, Di-Poi et al (2002) showed that the addition
of tumor necrosis factor-a to cultured mouse keratinocytes sti-
mulated MMP-9 via a pathway involving the peroxisome prolif-
erator activated receptor-d/b and the PI3 kinase cascade. The
authors argued that, in this biologic system, the addition of tu-
mor necrosis factor-a mimics the wound healing process (Tan
et al, 2001). In human keratinocytes, using a scratch wounding
system, we clearly show that the injury-mediated stimulation of
MMP-9 involves a di¡erent pathway as it is totally insensitive to
LY294002, a PI3 kinase inhibitor.
Similarities exist between tumoral progression and wound
healing (Dvorak, 1986). The fact that MMP-9 plays an active part
both in tumoral invasion and wound healing supports this idea.
The mechanisms responsible for the overexpression of MMP-9 in
tumor cells remain unknown, and identi¢cation of the molecular
mechanisms regulating MMP-9 expression during wound heal-
ing may contribute to the understanding of the events associated
with the neoplasic transformation in keratinocytes.
The identi¢cation of Rho family of GTPases in the signaling
cascade that controls MMP-9 in healing keratinocytes is the third
valuable new information resulting from this study. So far inves-
tigations have focused on the contribution of Rho, Rac, and
Cdc42 in the control of cell motility and adhesion (Nobes and
Hall, 1999; Nguyen et al, 2001). Studies performed on rat embryo
¢broblasts showed that, during wound healing, the signal trans-
duction pathways controlled by the four small GTP binding
proteins Rho, Rac, Cdc42, and Ras, co-operate to promote cell
movement (Nobes and Hall, 1999). The activation of Rac and
Cdc42 induces lamellipodial/¢lopodial protrusion and membrane
ru¥ing at the leading edge of the wound and thus regulate the
migration stage. Moreover, Rho activity is required to maintain
cell^substrate adhesion. Elsewhere, it has been shown that RhoA
was required during embryonic wound healing for the formation
of actin cables (Brock et al, 1996). Using, a wounding model we
clearly demonstrate, that in adult NHK, the activities of three
GTPases are together stimulated by injury and are directly in-
volved in the molecular cascade linking cell injury to upregula-
tion of MMP-9. Interestingly our study shows that, in adult
keratinocytes the stimulation of MMP-9 involves Rho activation,
but is independent of the actin cytoskeleton rearrangement as de-
termined by the insensitivity of the process to cytochalasin B.
This observation is consistent with reports of Sahai andTreisman
(1998) indicating that Rho A can mediate gene transcription in-
dependently from cytoskeletal changes. Accordingly, our results
demonstrate that, in wounded cell layers, the Rho family of
GTPases exerts a double action by (1) controlling the actin cytos-
keleton changes, and (2) upregulating MMP-9 expression.Activa-
tion of MMP-9 results in degradation of ECM proteins and thus
facilitates cell migration from the wound edge to the wound bed.
The fourth original point of this study concerns the identi¢ca-
tion of the molecular intermediaries linking injury-stimulated
Rho GTPases activation to stimulation of MMP-9. Several lines
of evidence indicate that Rho-related GTPases regulate gene ex-
pression through the activation of signaling cascades leading to
the increase of JNK, p38[MAPK], ERK1/2, and PI3 kinase activ-
ities (Coso et al, 1995; Zhang et al, 1995; Palsson et al, 2000; Murga
et al, 2002). Using pharmacologic inhibitors,ToxA, exoC3, and a
dominant negative variant of JNK, we demonstrate that JNK and
p38[MAPK] but not ERK1/2 nor PI3 kinase are located down-
stream the activation of the Rho GTPases and that these two ki-
nases likely constitute the molecular link between Rho proteins
and activation of MMP-9. By the mean of ToxA and/or exoC3
we also demonstrate that the injury-mediated activation of RhoA
preferentially controls the pathways leading to JNK stimulation,
whereas p38[MAPK] activation rather depends on the activation of
Rac and/or Cdc42. Interestingly, the essential role of JNK and
p38[MAPK] in MMP-9 induction correlates well with the presence
of AP-1 sites in MMP-9 promoter regulatory sequences (Yokoo
and Kitamura, 1996; Simon et al, 2001).
In conclusion, in this study we identi¢ed the signaling path-
ways underlying stimulation of the protease MMP-9, in
wounded human keratinocytes. We demonstrated that MMP-9
upregulation results from activation of at least two signaling
pathways. One involves Rac and/or Cdc42 and controls the acti-
vation of the kinase p38[MAPK], the second requires activation of
RhoA and JNK. Interestingly, this molecular cascade is speci¢c
for the wound healing process and di¡ers from the mechanisms
involved in MMP-9 upregulation in tumor cells. Because MMP-
9 is deregulated in several pathologies associated with abnormal
wound healing (Ladwig et al, 2002; Lobmann et al, 2002), our
results pave the way to the understanding of MMP-9 expression
in abnormal wound healing process in view of the development
of strategies for the treatment of chronic wounds or keloids.
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